Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Results 1 - 20 of 438 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar gameguru (33.49) Submitted: 2/12/2016 12:41:32 PM : Outperform Start Price: $89.43 GILD Score: +0.21

Competitive position is eroding, but huge cash machine ready to support expansion. Market is expecting a lot of pricing risk.

Recs

0
Member Avatar jsn1080 (22.12) Submitted: 2/8/2016 2:12:17 PM : Outperform Start Price: $85.00 GILD Score: +3.98

Incredible valuation at current price

Recs

0
Member Avatar Hugo1900 (< 20) Submitted: 1/30/2016 3:55:00 PM : Outperform Start Price: $82.32 GILD Score: +12.33

Stock is highly undervalued.

Recs

0
Member Avatar TygerSpark (39.10) Submitted: 1/29/2016 2:41:24 PM : Outperform Start Price: $82.99 GILD Score: +11.14

I don't think you would go wrong with Celgene or Gilead. I like the future prospects of both.

Recs

0
Member Avatar KEBowman (33.68) Submitted: 1/18/2016 6:05:40 PM : Outperform Start Price: $91.17 GILD Score: -0.15

a biotech super star

Recs

0
Member Avatar saile (< 20) Submitted: 1/15/2016 6:56:24 PM : Outperform Start Price: $88.99 GILD Score: +1.01

biotech growth due to worldwide demographics and increases in older age populations around the world

Recs

0
Member Avatar ffain (< 20) Submitted: 1/4/2016 7:32:15 AM : Outperform Start Price: $99.77 GILD Score: -2.86

Nice chart, healthcare is going up for sure.

Recs

0
Member Avatar txjoe79 (< 20) Submitted: 12/28/2015 9:31:19 PM : Outperform Start Price: $102.25 GILD Score: -2.33

Established as main cog for treatments in need areas of medicine- with more FDA approvals pending. Good platform.

Recs

0
Member Avatar JohnEKnudson (35.38) Submitted: 12/23/2015 7:02:18 PM : Outperform Start Price: $103.35 GILD Score: -3.61

Cash flow is solid as is the thesis on future cash flow from current drugs. The pharma industry should also rebound with the arrest of the CEO who practiced predatory pricing.

Recs

0
Member Avatar Folsomike (32.72) Submitted: 12/22/2015 4:17:09 PM : Outperform Start Price: $102.75 GILD Score: -3.55

Well managed, quality company with tremendous momentum and priced at a value.

Recs

0
Member Avatar SgtTurbo (70.84) Submitted: 12/12/2015 1:09:25 PM : Outperform Start Price: $99.97 GILD Score: -2.31

GILD was the first stock I bought. Wish I had bought more, sooner.

Recs

0
Member Avatar FVelociraptor (99.08) Submitted: 11/12/2015 10:51:24 AM : Outperform Start Price: $103.45 GILD Score: -4.30

http://velociraptor.cc

Recs

0
Member Avatar PSX5205 (55.10) Submitted: 11/2/2015 4:53:26 PM : Outperform Start Price: $108.93 GILD Score: -6.22

Excellent long term potential with great pipeline of drugs. Recently added dividend makes it a contender for new institutional investors. Recently beaten up sector with high probability of a turnaround to new highs.

Recs

0
Member Avatar yooperking (45.92) Submitted: 10/23/2015 9:19:31 AM : Outperform Start Price: $108.00 GILD Score: -6.67

AbbVie's loss on their Hepititis C drug is Gilead's gain. Furthermore, Gilead's 8.77 Fwd PE ratio is the lowest in the industry, in addition to them having the highest profit and operating margins and return on assets/equity percentages in the industry.

Recs

0
Member Avatar jstaack (46.42) Submitted: 10/1/2015 4:18:51 PM : Outperform Start Price: $95.13 GILD Score: -3.71

great pipeline and management team.

Recs

0
Member Avatar Aaaaaaaa (< 20) Submitted: 9/28/2015 12:02:56 PM : Outperform Start Price: $96.25 GILD Score: -5.09

What is lower limit

Recs

0
Member Avatar ruinas (25.56) Submitted: 9/25/2015 3:08:21 PM : Outperform Start Price: $99.04 GILD Score: -6.32

expect maintainence of improving earnings

Recs

0
Member Avatar bachole (< 20) Submitted: 9/24/2015 4:27:08 PM : Outperform Start Price: $103.58 GILD Score: -8.94

Huge potential for acquisitions and great history of products. Market leader not follower during scary times. Despite Clinton's comments, I'd say Gilead continues to churn out profits better than your industry average.

Recs

0
Member Avatar DutchBlue (< 20) Submitted: 9/23/2015 2:57:34 AM : Outperform Start Price: $97.53 GILD Score: -5.16

Great money making machine.

Recs

0
Member Avatar sk2129 (34.47) Submitted: 9/18/2015 10:10:12 AM : Outperform Start Price: $86.54 GILD Score: +1.09

baker bros

Featured Broker Partners